Related Experiment Video
Updated: Apr 10, 2026
Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
Recurrent CDKN1B (p27) mutations in hairy cell leukemia
Sascha Dietrich1, Jennifer Hüllein2, Stanley Chun-Wei Lee3
1Department of Medicine V, University Hospital Heidelberg, Genome Biology Unit, European Molecular Biology Laboratory, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany;
Hairy cell leukemia (HCL) frequently harbors BRAFV600E mutations. This study reveals CDKN1B mutations in 16% of HCL patients, suggesting a role in cell cycle regulation and senescence.
Area of Science:
- Hematology
- Oncology
- Cancer Genetics
Background:
- Hairy cell leukemia (HCL) is characterized by near-universal BRAFV600E mutations.
- Cooperating genetic events in HCL pathogenesis remain largely undescribed.
Purpose of the Study:
- To investigate the broader mutational landscape of purine analog-refractory HCL.
- To identify novel genetic alterations beyond BRAFV600E that may contribute to HCL.
Main Methods:
- Whole exome sequencing was performed on purine analog-refractory HCL samples.
- Targeted deep sequencing of CDKN1B was conducted in a larger HCL cohort (n=81).
Main Results:
- BRAFV600E mutations were confirmed, alongside mutations in EZH2 and ARID1A.
- Recurrent inactivating mutations in the cell cycle inhibitor CDKN1B (p27) were identified in 16% of HCL patients.
- CDKN1B mutations were clonal in most cases, indicating an early role in HCL development, but did not affect clinical outcomes.
Conclusions:
- HCL exhibits a high frequency of CDKN1B mutations, second only to BRAFV600E.
- These findings suggest a novel role for cell cycle dysregulation and senescence in HCL pathogenesis.
- CDKN1B mutations represent a significant, previously underappreciated genetic event in HCL.
More Related Videos
09:09Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation
Published on: November 10, 2017
07:01Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting
Published on: May 2, 2025
Related Concept Videos
02:34Inhibition of Cdk Activity
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:23Abnormal Proliferation
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:15M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
02:21Cancers Originate from Somatic Mutations in a Single Cell